Last edition
News about Market
Atrium Therapeutics receives a USD 15 million milestone payment from Bristol Myers Squibb under a global collaboration to develop innovative RNA-based therapies for cardiovascular diseases.
Market | 24/04/2026 | By News Bureau | 100
Nektar Therapeutics Closes USD 373.8 Million Public Offering
Nektar Therapeutics completes USD 373.8 million public offering, including full exercise of underwriters’ option to purchase additional shares.
Market | 24/04/2026 | By News Bureau
Andelyn Biosciences and ENCell Forge Global Manufacturing Alliance
Andelyn Biosciences and ENCell partner to build a cross-continental manufacturing network, enabling faster development and global delivery of advanced gene therapies.
Market | 23/04/2026 | By News Bureau
Amneal Pharmaceuticals to Acquire Kashiv BioSciences to Create Integrated Global Biosimilar Platform
Amneal Pharmaceuticals to buy Kashiv BioSciences, accelerating biosimilar pipeline and strengthening US market position for affordable medicines.
Market | 23/04/2026 | By News Bureau
Zyax Chem Buys 26 Percent Stake in Gaymed Labs
Zyax Chem acquires 26 percent stake in Gaymed Labs, securing board representation and boosting expansion in the ophthalmic segment.
Market | 22/04/2026 | By News Bureau
Lupin Launches Diabetes Drug Combination in the US
Lupin launches dapagliflozin and metformin extended-release tablets in the US, offering a bioequivalent and cost-effective alternative for type 2 diabetes management.
Market | 22/04/2026 | By News Bureau | 130
Merck Launches Bio-Based Solvents for Sustainable HPLC Applications
Merck introduces bio-based HPLC solvents made from renewable feedstocks, offering lower carbon emissions while maintaining performance for advanced laboratory and analytical applications.
Market | 22/04/2026 | By News Bureau | 204
Raay Neo Pharma Launches Operations with Focus on Expanding Access to Medicines
Raay Neo Pharma plans to introduce 90 plus formulations across acute and specialty therapies along with its entry in the India’s Pharmaceutical sector, aiming to strengthen healthcare access across multiple Indian states through a scalable and patient-centric model.<br />
Market | 22/04/2026 | By News Bureau | 127
SynSmart and Amporin Partner to Develop Small Molecule Therapies for Degenerative Diseases
SynSmart and Amporin collaborate to develop breakthrough small molecule therapeutics for degenerative diseases, with SynSmart creating a library of novel membrane-protecting molecules at its Mumbai research facility.
Market | 22/04/2026 | By News Bureau | 107
Asahi Kasei expands its global pharmaceutical footprint with the acquisition of Aicuris, strengthening its pipeline in infectious diseases and advancing treatments for immunocompromised patients.
Market | 21/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy